Posted by Michael Wonder on 29 Nov 2020
Drug change not ruled out as factor in epilepsy death, neurologist's report says
29 November 2020 - The first official recognition that changing brands of epilepsy drugs may have been a factor in at least one of six deaths has come to light as a Chief Coroner's inquest into the brand switch opens today.
A neurologist's report to the Coroner says changing brands of the anti-seizure drug lamotrigine could not be ruled out as a factor in the death of 31-year-old Auckland man Andre Maddock in December last year.
